ホームDEMG • LON
add
Deltex Medical Group plc
市場ニュース
財務情報
損益計算書
収益
純利益
(GBP) | 2024年6月info | 前年比変化率 |
---|---|---|
収益 | 53.20万 | 0.47% |
営業費用 | 57.65万 | 0.70% |
純利益 | -27.30万 | -1.68% |
純利益率 | -51.32 | -1.20% |
1 株当たりの収益 | — | — |
EBITDA | -20.15万 | -6.33% |
実効税率 | — | — |
貸借対照表
総資産
負債総額
(GBP) | 2024年6月info | 前年比変化率 |
---|---|---|
現金および短期投資 | 32.60万 | 204.67% |
総資産 | 550.00万 | -7.47% |
負債総額 | 281.20万 | -31.48% |
純資産 | 268.80万 | — |
発行済み株式 | 18.92億 | — |
帳簿価格 | ∞ | — |
総資産利益率 | -10.05% | — |
資本利益率 | -11.83% | — |
キャッシュ フロー
現金の純増減額
(GBP) | 2024年6月info | 前年比変化率 |
---|---|---|
純利益 | -27.30万 | -1.68% |
営業キャッシュ フロー | -21.75万 | -42.62% |
投資キャッシュ フロー | 1000.00 | 100.83% |
財務キャッシュ フロー | 2.15万 | -77.37% |
現金の純増減額 | -18.95万 | -4.12% |
フリー キャッシュ フロー | -11.31万 | 53.54% |
概要
Deltex Medical Group is a medical technology company based in Chichester that produces blood monitoring and fluid management equipment for use in surgical operations.
It has sold 3000 of its main product, the ultrasound probe CardioQ-ODM, which measures the rate of blood flow from the heart. The company claims that it has been shown to reduce postoperative complications and reduce length of hospital stay. According to the National Institute for Health and Care Excellence it could save £1000 per operation and could be used on more than 800,000 patients a year. As it is inserted into the gullet, it reduces the risk of infection that comes with monitoring using a tube inserted through a vein into the heart. Each probe costs about £100.
It secured approval from the NHS Supply Chain in 2012 after a tender process, to sell cardiac output monitoring equipment to the NHS in England, meaning that individual NHS trusts did not have to go through a tender process. In November 2016 an NHS hospital bought six, the largest order since 2014. The cash crisis affecting the NHS has meant that few machines have been bought. Wikipedia
設立
2000
ウェブサイト
従業員数
24